Switch to:
More From Other Websites
Genmab Announces European Conditional Marketing Authorization for DARZALEX® (daratumumab) for... May 23 2016
First Participants Dosed in Clinical Study with DuoBody® Product May 20 2016
Articles of Association for Genmab A/S May 19 2016
GENCOR INDUSTRIES INC Financials May 19 2016
Daratumumab and Ofatumumab Data to Be Presented at 21st Congress of EHA May 19 2016
Genmab Announces Positive Topline Result in Phase III POLLUX Study of Daratumumab in Relapsed or... May 18 2016
Capital Increase in Genmab as a Result of Employee Warrant Exercise May 18 2016
Ofatumumab in Combination with Fludarabine and Cyclophosphamide for Relapsed CLL accepted for... May 17 2016
Genmab Announces Financial Results for the First Quarter of 2016 May 10 2016
GENCOR INDUSTRIES INC Files SEC form 10-Q, Quarterly Report May 10 2016
GENCOR INDUSTRIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 10 2016
Gencor posts 2Q profit May 09 2016
Gencor posts 2Q profit May 09 2016
Gencor Releases Second Quarter Fiscal 2016 Results May 09 2016
Articles of Association for Genmab A/S May 02 2016
Genmab Announces Daratumumab Data to be Presented at 2016 ASCO Annual Meeting Apr 20 2016
Genmab Updates Financial Guidance for 2016 Apr 20 2016
ETF’s with exposure to Gencor Industries, Inc. : April 8, 2016 Apr 08 2016
Gencor Industries, Inc. :GENC-US: Earnings Analysis: Q1, 2016 By the Numbers Apr 07 2016
Patent Infringement Lawsuit Filed Against Genmab and Janssen in the United States Regarding... Apr 04 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK